Patent ID: 8075880

Claim:
A method for delivering an endothelial progenitor cell to a site of angiogenesis in a human patient, the method comprising: administering to the patient a composition comprising a human CD34 + cell, wherein the composition is enriched for human CD34 + cells relative to peripheral blood, and wherein the endothelial progenitor cell is isolated using an antibody specific for human CD34, and a polypeptide selected from the group consisting of acidic FGF, basic FGF, vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), transforming growth factor α and β (TGF-α and TGF-β), platelet-derived endothelial growth factor (PD-ECGF), platelet-derived growth factor (PDGF), tumor necrosis factor α (TNF-α), hepatocyte growth factor (HGF), insulin like growth factor (IGF), erythropoietin, colony stimulating factor (CSF), macrophage-CSF (M-CSF), granulocyte/macrophage CSF (GM-CSF) and nitric oxide synthase (NOS).